Italian Founders Fund

Italian Founders Fund is one of the more deliberate attempts in the past decade to build a community-led early-stage capital structure inside Italy, and its founder-built character is the most important context for evaluating a relationship with the firm. Founded in 2022 and based in Milan, the fund is co-managed alongside Koinos Capital and was structured around contributions from successful Italian entrepreneurs who wanted to channel capital and operating experience into the next cohort of Italian technology founders. The vehicle is small by international standards but unusually well-positioned within the Italian ecosystem, where institutional pre-seed and seed capital remains structurally undersupplied relative to the volume of credible technical founders emerging from Italian universities and corporate operator networks.

The stated thesis is to back Italian and Italy-connected founders at the earliest stages, with a clear preference for technical teams building software and applied technology businesses with global ambition. The fund is geographically focused but not parochial; partners have been explicit that they want Italian founders building for international markets rather than for the Italian domestic market alone. In healthcare specifically the firm operates at the digital health and clinical software layer rather than therapeutics or medical devices, and the orientation is toward operational software for healthcare providers and consumer-facing health products rather than regulated clinical infrastructure. AI is treated as an enabling layer across the portfolio rather than a discrete thesis area.

The portfolio currently spans roughly 15 companies across pre-seed, seed and Series A. Salupay, a revenue collection software platform for healthcare clinics, is the clearest digital health bet in the disclosed portfolio. The broader portfolio includes Jet HR, a digital payroll and HR platform for small and medium businesses; Glaut, an AI-native market research platform; Skillvue, an AI-based skills assessment platform; and additional positions in TaDa, Sava Technologies, which is developing a continuous glucose monitor for the consumer glucose monitoring market with Italian co-founders Renato Circi and Rafael Michali, and ReportAId. For digital health founders the relevant signal is that the fund is willing to lead pre-seed and seed rounds in Italian-origin healthcare software, and that the syndicate partners it has assembled, including Balderton Capital, Pentland Ventures, Norrsken VC, JamJar Investments, True and others, materially improve the follow-on capital pathway from Italian seed to international Series A.

On stage and check size, the fund operates at pre-seed and seed with stated check sizes in the USD 250,000 to USD 1 million range. The firm is willing to write the first institutional check into Italian companies and frequently co-invests with international seed funds at the same round. Founders raising larger seed rounds with international co-leads will find the firm a credible Italian anchor, and founders raising primary pre-seed financing will find a partner willing to underwrite formation risk. Reserve allocation supports follow-on participation in subsequent rounds when execution justifies it.

Decision-making is community-led in character and structurally collaborative. The fund’s investor base of successful Italian entrepreneurs serves as both LP base and informal advisory network, and portfolio companies typically gain access to a meaningful operator community in addition to the formal capital relationship. The Milan-based investment team manages day-to-day diligence and portfolio relationships in coordination with Koinos Capital.

The most reliable approach is through the Italian operator community. The firm sources heavily from existing portfolio CEOs, Italian university networks and the broader Milan technology community, and warm referrals from those channels materially improve the conversion rate. Direct outreach via the website is read, but founders are better served arriving with an introduction from an Italian operator or from one of the firm’s existing international syndicate partners.

What founders should know is that Italian Founders Fund is the most credible community-led pre-seed and seed vehicle in the Italian ecosystem, and that its value extends well beyond the financial check into the operator network that surrounds it. The fund will not be the right partner for capital-intensive therapeutics or medical device builds, but is a strong fit for Italian-origin digital health and software founders with international ambition. For builders raising their first institutional round in Italy, the firm represents one of the more strategically useful capital sources currently available.